![]() |
Expression of Prostaglandin E2 Receptors in Acquired Middle Ear Cholesteatoma
Sujie Wang, Li Xie, Yanfei Zhang, Pengfei Xu, Aiguo Liu
Clin Exp Otorhinolaryngol. 2018;11(1):17-22. Published online 2017 Aug 26 DOI: https://doi.org/10.21053/ceo.2017.00304
|
Citations to this article as recorded by
The Science of Cholesteatoma
Tirth R. Patel, Christopher M. Welch
Otolaryngologic Clinics of North America.2025; 58(1): 1. CrossRef Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma
Lingling Zeng, Li Xie, Jin Hu, Chao He, Aiguo Liu, Xiang Lu, Wen Zhou
Cell Cycle.2024; 23(5): 537. CrossRef Review of potential medical treatments for middle ear cholesteatoma
Matthias Schürmann, Peter Goon, Holger Sudhoff
Cell Communication and Signaling.2022;[Epub] CrossRef The Effect of Oral Montelukast Administration in Cholesteatoma Development and Inflammation: An Experimental Animal Model
Ramazan Ocal, Selda Kargin Kaytez, Nihat Yumusak, Ozlem Akkoca, Hatice Celik, Necmi Arslan
Otology & Neurotology.2021; 42(5): e568. CrossRef miR‐199a Targeting PNRC1 to Promote Keratinocyte Proliferation and Invasion in Cholesteatoma
Lihui Yao, Wenjing Zhang, Jian Zheng, Xing Lu, Fan Zhang, Yoshiyuki Morishita
BioMed Research International.2021;[Epub] CrossRef Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)
Xiaoting Sun, Qi Li
International Journal of Molecular Medicine.2018;[Epub] CrossRef
|